Dramatic response after an intravenous loading dose of azathioprine in one case of severe and refractory ankylosing spondylitis

被引:12
作者
Durez, P
Horsmans, Y
机构
[1] Free Univ Brussels, Hop Erasme, Dept Rheumatol, B-1070 Brussels, Belgium
[2] Sch Med, Dept Gastroenterol, Louvain, Belgium
关键词
ankylosing spondylitis; intravenous azathioprine;
D O I
10.1093/rheumatology/39.2.182
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe a 37-yr-old Caucasian male suffering from ankylosing spondylitis (AS) with long standing severs inflammatory lumbar pain and hip arthritis who was refractory to nonsteroidal anti-inflammatory drugs, sulphasalazine and methotrexate up to 25 mg/week. In this patient, administration of an i.v. loading dose of azathioprine (AZA: 40 mg/kg for 36 h Followed by 2 mg/kg oral AZA therapy) induced a dramatic response in his clinical condition. Indeed. objective and subjective clinical variables improved within 1 week and were corroborated by a decline in the levels of the inflammatory parameters; anaemia was reported at month 3 but was rapidly reversible. If confirmed. an i.v. loading dose of AZA could represent a valuable alternative in severe and refractory AS, but toxicity of this regimen should be carefully analysed.
引用
收藏
页码:182 / 184
页数:3
相关论文
共 13 条
[1]  
AMOR B, 1994, J RHEUMATOL, V21, P1883
[2]   THE NATURAL DISEASE COURSE OF ANKYLOSING-SPONDYLITIS [J].
CARETTE, S ;
GRAHAM, D ;
LITTLE, H ;
RUBENSTEIN, J ;
ROSEN, P .
ARTHRITIS AND RHEUMATISM, 1983, 26 (02) :186-190
[3]  
CREEMERS MCW, 1994, BRIT J RHEUMATOL, V33, P842
[4]  
CREEMERS MCW, 1995, J RHEUMATOL, V22, P1104
[5]  
FERRAZ MB, 1990, J RHEUMATOL, V17, P1482
[6]  
GALENS GJ, 1964, ARTHRITIS RHEUM, V7, P735
[7]  
KLIEM V, 1994, TRANSPLANT P, V26, P2553
[8]   THE CLINICAL-PHARMACOLOGY OF 6-MERCAPTOPURINE [J].
LENNARD, L .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (04) :329-339
[9]   PHARMACOGENETICS OF ACUTE AZATHIOPRINE TOXICITY - RELATIONSHIP TO THIOPURINE METHYLTRANSFERASE GENETIC-POLYMORPHISM [J].
LENNARD, L ;
VANLOON, JA ;
WEINSHILBOUM, RM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (02) :149-154
[10]  
LEQUINTREC JL, 1990, REV RHUM, V57, P815